Abstract
Most daunting threat for humankind is the corona virus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2. Various vaccine production platforms are available, each with distinct advantages and obstacles. Pharmaceutical formulation science plays a critical role in the race for a safe, effective coronav virus disease vaccine (COVID)-19. The target population of vaccinees includes high-risk individuals over the age of 60, those with chronic co-morbid conditions, frontline healthcare workers, and those involved in critical industries. Once a safe and reliable vaccine policy becomes available, pre-pandemic normalcy will never return. As COVID-19 continues to wreak havoc on people's health and livelihoods around the world, the prospect of an effective vaccine may appear to be a silver bullet. Despite this, a number of challenges remain, each of which necessitates careful and ongoing debate to ensure that vaccination strategies are safe, appropriate, and realistic. So the best way forward is simply to register oneself on Aarogya Setu and get vaccinated as soon as possible, regardless of Covishield or Covaxin.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
